Location: Vienna, Austria

Date: 08/11/26 to 11/11/26

ISPOR Europe 2026

YHEC is excited to join other global healthcare leaders, researchers and decision-makers at ISPOR Europe 2026 in Vienna, Austria. 11 staff members are representing YHEC at ISPOR Europe this year, including our CEO, Director of Pharmaceutical Consulting, Director of Digital Health Technologies Consulting and Director of Reviews and Evidence Synthesis. We will be presenting 17 posters and panels over the course of three days, and you can find us at Booth 719. If you would like to arrange a meeting with our team at ISPOR, please contact us.

Issue panel

We are delighted to be participating in an issue panel. The details of this session can be found below:

Research Posters

We are also pleased to be presenting 16 posters at ISPOR EU 2026. The titles of our research, alongside the times and dates of each poster session, are listed below:

HTA47: PRISMA-Perfect? Checking ISPOR Abstracts’ Alignment with PRISMA-A 2020

Date: Monday 09 November
Poster session: 10:30 to 13:30
Discussion period: 12:30 to 13:30

MSR52: The Covidence relevance ranking tool for accelerating screening in literature review

Date: Monday 09 November
Poster session: 10:30 to 13:30
Discussion period: 12:30 to 13:30

HTA133: Review of evidence underpinning recommendations in past NICE HealthTech guidance

Date: Monday 09 November
Poster session: 16:00 to 19:00
Discussion period: 18:00 to 19:00

SA57: Targeted Review Methods to Identify Clinical Outcomes Assessment Instruments in Long-Covid and Post-Covid Vaccination Syndrome

Date: Tuesday 10 November
Poster session: 10:30 to 13:30
Discussion period: 12:30 to 13:30

CO107: Systematic Literature Review, Feasibility Assessment and Network Meta-Analysis of Treatments for Complicated Urinary Tract Infections caused by Gram negative Pathogens

Date: Tuesday 10 November
Poster session: 10:30 to 13:30
Discussion period: 12:30 to 13:30

CO139: Reactogenicity of nuvaxovid and other commercialized COVID-19 vaccines: a systematic review of randomized controlled trials

Date: Tuesday 10 November
Poster session: 10:30 to 13:30
Discussion period: 12:30 to 13:30

HTA378: The Willingness to Reimburse: A Scoping Review of Approaches to Global HTA Thresholds

Date: Wednesday 11 November
Poster session: 09:00 to 11:30
Discussion period: 10:30 to 11:30

HPR173: Tackling socioeconomic inequalities associated with meningitis and encephalitis and the role of rapid multiplex testing

Date: Tuesday 10 November
Poster session: 16:00 to 19:00
Discussion period: 18:00 to 19:00

HPR227: Hernia risk, deprivation and fairer prevention

Date: Wednesday 11 November
Poster session: 09:00 to 11:30
Discussion period: 10:30 to 11:30

HPR228: Distributional cost-effectiveness analysis: a case study of ventral hernias in England and the role of targeted implementation

Date: Wednesday 11 November
Poster session: 09:00 to 11:30
Discussion period: 10:30 to 11:30

EE189: The clinical, economic and operational benefits of implementing the bundled HIV, Hepatitis B and syphilis Determine antenatal care panel for pregnant women in Rwanda

Date: Monday 09 November
Poster session: 16:00 to 19:00
Discussion period: 18:00 to 19:00

EE266: The financial impact of system down-time during robot-assisted general surgeries in the United Kingdom

Date: Monday 09 November
Poster session: 16:00 to 19:00
Discussion period: 18:00 to 19:00

EE381: Cost-effectiveness of Ion as a biopsy tool for patients currently ineligible for biopsy in the lung cancer diagnostic pathway

Date: Tuesday 10 November
Poster session: 10:30 to 13:30
Discussion period: 12:30 to 13:30

HTA220: Can MCDA informed AI improve consistency in HTA decisions

Date: Tuesday 10 November
Poster session: 16:00 to 19:00
Discussion period: 18:00 to 19:00

HSD64: Informing Economic Model Conceptualisation With A Care Pathway Analysis For A Robot-Assisted Bronchoscopy Platform For Suspicious Pulmonary Nodules In The UK

Date: Tuesday 10 November
Poster session: 10:30 to 13:30
Discussion period: 12:30 to 13:30

EE453: Challenges in economic modelling for female specific health conditions

Date: Tuesday 10 November
Poster session: 10:30 to 13:30
Discussion period: 12:30 to 13:30